USANA (Nasdaq: USNA) reported Q3 EPS of $0.70, 4 cents better than the analysts estimates $0.66. Revenues for the quarter were $106.2 million, versus the consensus of $106.44 million. Company sees Q4 earnings from $0.66 to $0.68 versus a consensus of $0.68. Q4 revenues sees $108 million to $110 million, while consensus was $112 million.

USANA Health Sciences, Inc. (USANA) develops and manufactures science-based nutritional and personal care products.